Dr. Mangalmurti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Old Lancaster Rd
Suite 410
Bryn Mawr, PA 19010Phone+1 610-527-1165Fax+1 610-527-6611
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Interventional Cardiology, 2008 - 2009
- UPMC Medical EducationFellowship, Cardiovascular Disease, 2005 - 2008
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2006
- NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2005
- New York University School of MedicineClass of 2001
Certifications & Licensure
- NJ State Medical License Current
- PA State Medical License 2005 - 2026
- NY State Medical License 2008 - 2011
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Disrupt PAD III Observational Study.Ehrin J Armstrong, George Adams, Peter A Soukas, Sarang S Mangalmurti, Nicolas W Shammas
Journal of Endovascular Therapy. 2024-10-18 - 2 citationsIntravascular Lithotripsy for Treatment of Severely Calcified Common Femoral Artery Disease: Results From the Disrupt PAD III Observational Study.Nicolas W Shammas, Sarang Mangalmurti, Nelson L Bernardo, Anderson Mehrle, George Adams
Journal of Endovascular Therapy. 2024-06-15 - 2 citationsSex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study.Sameer Nagpal, S Elissa Altin, Katharine McGinigle, Sarang S Mangalmurti, George Adams
Journal of Vascular Surgery. 2024-02-01
Press Mentions
- Sectoral Asset Management Makes $9M Investment into Cagent VascularJune 17th, 2021
- Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 ResultsOctober 22nd, 2020
- ‘I Thought I Was Going to Die’: First-of-Its-Kind Treatment Uses Sound Waves to Treat Common Heart ConditionJune 17th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: